|
Volumn 24, Issue 6, 2007, Pages 1233-1239
|
Probrain natriuretic peptide for assessment of efficacy in heart failure treatment
|
Author keywords
Heart failure; Natriuretic peptide; Spironolactone; Therapy
|
Indexed keywords
AMINO TERMINAL PRO BRAIN NATRIURETIC PEPTIDE;
CREATININE;
PLACEBO;
SPIRONOLACTONE;
ALDOSTERONE RECEPTOR;
BIOLOGICAL MARKER;
BRAIN NATRIURETIC PEPTIDE;
PEPTIDE FRAGMENT;
PRO BRAIN NATRIURETIC PEPTIDE (1 76);
PRO-BRAIN NATRIURETIC PEPTIDE (1-76);
UNCLASSIFIED DRUG;
AGED;
ARTICLE;
BLOOD SAMPLING;
CLINICAL FEATURE;
CLINICAL TRIAL;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
CREATININE BLOOD LEVEL;
DISEASE CLASSIFICATION;
DRUG EFFICACY;
DRUG WITHDRAWAL;
FEMALE;
HEART EJECTION FRACTION;
HEART FAILURE;
HUMAN;
HYPERKALEMIA;
MAJOR CLINICAL STUDY;
MALE;
PROTEIN BLOOD LEVEL;
RANDOMIZED CONTROLLED TRIAL;
SIDE EFFECT;
BLOOD;
DRUG ANTAGONISM;
HEART STROKE VOLUME;
PATHOPHYSIOLOGY;
PROSPECTIVE STUDY;
AGED;
BIOLOGICAL MARKERS;
FEMALE;
HEART FAILURE;
HUMANS;
MALE;
NATRIURETIC PEPTIDE, BRAIN;
PEPTIDE FRAGMENTS;
PROSPECTIVE STUDIES;
RECEPTORS, ALDOSTERONE;
SPIRONOLACTONE;
STROKE VOLUME;
|
EID: 41749096636
PISSN: 0741238X
EISSN: None
Source Type: Journal
DOI: 10.1007/BF02877769 Document Type: Article |
Times cited : (5)
|
References (19)
|